Respicardia
Minnetonka
About Respicardia
Respicardia (formerly Cardiac Concepts) is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health. The first product, the remed─ô® System, is an implantable stimulation device that is designed to restore a more normal breathing pattern during sleep for patients with central sleep apnea. Respicardia® is committed to improving cardiovascular health…one breath at a time™.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $160.2M
- Funding stage: M&A
- Last round: Series Unknown (Dec 2017)
- Website: respicardia.com
- Phone: (952)540-4470
Industries & Categories
Health Care, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/respicardia-81747 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.